Israel already has more than 44% of its population vaccinated with the two doses of Pfizer’s formula against COVID-19

The number of Israelis vaccinated with the two doses of the coronavirus vaccine exceeded today the four million, what represents just under half of the population and this has made it possible to maintain the downward trend in infections while returning to near-normality.

According to figures from the Israeli Ministry of Health, 55% of its roughly 9 million people have received at least one dose of Pfizer vaccine, while 44% were also inoculated with the second.

In the past month, alongside its rapid vaccination campaign, the rate of positive coronavirus tests has fallen from 8% to 3.1% recorded yesterday.

The Our World in Data chart which compares the progress of vaccination in each country per 100 inhabitants

The average age of new cases detected has also dropped sharply after vaccination of older people, the vast majority of whom already received both doses a long time ago.

Another encouraging statistic is the number of patients in serious condition, who in the last month it has grown from around 1000 to just over 600.

These indicators were essential for the government decided to reopen, last Sunday, bars, cafes and restaurants across the country, at the same time as moving back to class of the majority of students who were still studying virtually.

These measures, which favor the vaccinated population and the carriers of the “green pass” for the vaccinated, also included the reopening of rooms for cultural events, places of worship and even stadiums and auditoriums.

At the same time, local researchers worked around the clock to produce studies of the vaccine’s effectiveness in the population, which not only confirmed Pfizer’s clinical trial results, but were even used by the pharmaceutical company. to show that the vaccine is more effective than previously thought.

“We knew it was appropriate for humanity to be able to select a country where we could demonstrate how immunizing people can impact health rates, human health and economic rates, as they would be able to to reopen their economy. ”Explained yesterday the CEO of Pfizer, Albert Bourla, during an interview with the Channel 12 From Israel.

(With information from EFE)

KEEP READING: